Cargando…
PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer
PLA2G16 is a member of the phospholipase family that catalyses the generation of lysophosphatidic acids (LPAs) and free fatty acids (FFAs) from phosphatidic acid. In the current study, we explored the functional role of PLA2G16 in pancreatic adenocarcinoma (PAAD) and the genetic/epigenetic alteratio...
Autores principales: | Xia, Wei, Bai, Hansong, Deng, Ying, Yang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686977/ https://www.ncbi.nlm.nih.gov/pubmed/32985124 http://dx.doi.org/10.1111/jcmm.15832 |
Ejemplares similares
-
The KLF14 Transcription Factor Regulates Glycolysis by Downregulating LDHB in Colorectal Cancer
por: Wu, Guiyang, et al.
Publicado: (2019) -
KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
por: Mi, Wei, et al.
Publicado: (2022) -
SLC45A4 promotes glycolysis and prevents AMPK/ULK1‐induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma
por: Chen, Wenying, et al.
Publicado: (2021) -
The transcription factor KLF14 regulates macrophage glycolysis and immune function by inhibiting HK2 in sepsis
por: Yuan, Yuan, et al.
Publicado: (2022) -
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway
por: Li, Lin, et al.
Publicado: (2016)